{"product_id":"alcohol-drugs-and-medication-in-pregnancy-isbn-9781898683889","title":"Alcohol, Drugs and Medication in Pregnancy","description":"\u003cb\u003eClinics in Developmental Medicine No. 188\u003c\/b\u003e  \u003cp\u003eThis book documents the consequences of the exposure of infants to the influence of intrauterine chemicals. In setting out the evidence for these outcomes, the authors demonstrate that decisions about care and management can and should be made as early as possible. This should allow professionals to provide protective management and prevent the delays that are so often seen in this area of medical and social care.\u003c\/p\u003e \u003cp\u003eThe international team of contributors sets out to inform the reader of the potential risks to infants exposed to a range of intrauterine chemicals that are potentially neuroactive, including medicinal drugs such as antiepileptics, antidepressants and antipsychotics, as well as drugs of abuse, including alcohol, opiates, and recreational drugs such as cannabis and tobacco. They review the teratogenic action of some of the chemical processes and the relationship of exposure to the stage of pregnancy. Some agents alter anatomic structure; others alter the chemical balance of neurotransmitters and may thus alter the regulation of brain function, with profound effects on the child's behaviour and propensity to behavioural disturbances. The book explores strategies to support these children and those who care for them, including statutory agencies.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eReadership\u003cbr\u003e \u003c\/b\u003ePaediatricians, neonatologists, obstetricians, gynaecologists, child and adolescent psychiatrists and psychologists, those working in child care and child protection.\u003c\/p\u003e  \u003cp\u003eAUTHORS' APPOINTMENTS vii\u003c\/p\u003e \u003cp\u003e1. INTRODUCTION 1\u003cbr\u003e \u003ci\u003ePhilip M Preece\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION 1. NEUROTERATOGENESIS – EPIDEMIOLOGY AND PATHOLOGY\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e2. EPIDEMIOLOGY OF DRUG AND ALCOHOL USE DURING PREGNANCY 11\u003cbr\u003e \u003ci\u003eRon Gray\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3. NORMAL AND ABNORMAL EMBRYOGENESIS OF THE MAMMALIAN BRAIN 23\u003cbr\u003e \u003ci\u003eKathy K Sulik, Shonagh K O'Leary-Moore, Elizabeth A Godin and Scott E Parnell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION 2. LONG-TERM EFFECTS OF MAJOR PRESCRIBED MEDICATIONS\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e4. EPILEPSY IN PREGNANCY AND THE EFFECT OF PRENATAL ANTIEPILEPTIC MEDICATION 44\u003cbr\u003e \u003ci\u003eJill Clayton-Smith and Gus Baker\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5. NEURODEVELOPMENT OF CHILDREN EXPOSED TO ANTIDEPRESSANT AND ANTIPSYCHOTIC MEDICATIONS DURING PREGNANCY 56\u003cbr\u003e \u003ci\u003eIrene Nulman, Sara Citron, Michelle Todorow and Elizabeth Uleryk\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION 3. LONG-TERM EFFECTS OF DRUGS OF ABUSE\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e6. DIAGNOSIS OF FETAL ALCOHOL SYNDROME: EMPHASIS ON EARLY DETECTION 85\u003cbr\u003e \u003ci\u003eMargaret Barrow and Edward P Riley\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7. THE EFFECTS OF PRENATAL ALCOHOL EXPOSURE ON BRAIN AND BEHAVIOUR 108\u003cbr\u003e \u003ci\u003eChristie L McGee Petrenko and Edward P Riley\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8. EFFECT OF DRUGS OF ABUSE ON THE FETUS: COCAINE AND OPIATES INCLUDING HEROIN 130\u003cbr\u003e \u003ci\u003eLynn T Singer and Sonia Minnes\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9. CANNABIS USE DURING PREGNANCY: ITS EFFECTS ON OFFSPRING FROM BIRTH TO YOUNG ADULTHOOD 153\u003cbr\u003e \u003ci\u003ePeter A Fried\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10. IN UTERO EXPOSURE TO THE POPULAR 'RECREATIONAL' DRUGS MDMA (ECSTASY) AND METHAMPHETAMINE (ICE, CRYSTAL): PRELIMINARY FINDINGS 169\u003cbr\u003e \u003ci\u003eDerek G Moore, John J D Turner, Julia E Goodwin, Sarah E Fulton, Lynn T Singer and Andrew C Parrott\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11. THE SHORT-TERM AND LONG-TERM DEVELOPMENTAL CONSEQUENCES OF MATERNAL SMOKING DURING PREGNANCY 183\u003cbr\u003e \u003ci\u003eKate E Pickett and Lauren S Wakschlag\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSECTION 4. INTERVENTION STRATEGIES TO REDUCE THE IMPACT OF DRUGS AND ALCOHOL IN PREGNANCY\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e12. MANAGEMENT OF THE EFFECTS OF PRENATAL DRUGS IN CHILDREN OF DRUG-ABUSING PARENTS 197\u003cbr\u003e \u003ci\u003eFaye Macrory and Michael Murphy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13. PRENATAL AND POSTNATAL INTERVENTION STRATEGIES FOR ALCOHOL-ABUSING MOTHERS IN PREGNANCY 217\u003cbr\u003e \u003ci\u003eAnn P Streissguth and Therese M Grant\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14. COGNITIVE AND BEHAVIOURAL INTERVENTIONS TO AMELIORATE THE EFFECTS OF FETAL ALCOHOL SPECTRUM DISORDERS IN CHILDREN AND ADOLESCENTS: PROMOTING POSITIVE OUTCOMES 234\u003cbr\u003e \u003ci\u003eWendy O Kalberg and Julie Gelo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15. FETAL TERATOGEN SYNDROMES: PSYCHIATRIC ASPECTS AND MANAGEMENT 252\u003cbr\u003e \u003ci\u003eDavid J Bramble and Raja A S Mukherjee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16. RECOMMENDED MANAGEMENT OF COMMON MEDICAL PROBLEMS IN PREGNANCY: ADVICE FROM SPECIALIST AGENCIES 271\u003cbr\u003e \u003ci\u003eEvelyne Jacqz-Aigrain and Philip M Preece\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eINDEX 280\u003c\/p\u003e \u003cp\u003eCOLOUR PLATE SECTION\u003c\/p\u003e  \u003cb\u003ePhilip Preece\u003c\/b\u003e is a consultant paediatrician with training in neurodisability. He manages a range of children with autism spectrum disorders, attention-deficit hyperactivity disorder, and learning difficulties. He has developed an interest in the outcome of infants exposed to prenatal drugs, both medicinal and recreational, as part of his work assessing children prior to adoption.  \u003cp\u003e\u003cb\u003eEd Riley\u003c\/b\u003e served as Chair of the National Task Force on Fetal Alcohol Syndrome\/Fetal Alcohol Effect. He currently serves as the Steering Committee Co-Chair of the Fetal Alcohol Spectrum Disorders Center for Excellence. He has been President of the Research Society on Alcohol, the Fetal Alcohol Study Group, and the Behavioral Teratology Society. He has served as Associate Editor of the \u003ci\u003eJournal of Studies on Alcohol\u003c\/i\u003e, and is on the Editorial Boards of \u003ci\u003eAlcoholism: Clinical and Experimental Research\u003c\/i\u003e and the \u003ci\u003ePsychological Record\u003c\/i\u003e. He has received numerous awards for his scholarship and service, most recently the Research Society on Alcoholism Distinguished Researcher Award.\u003c\/p\u003e","brand":"Mac Keith Press","offers":[{"title":"Default Title","offer_id":47988711424229,"sku":"NP9781898683889","price":90.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781898683889.jpg?v=1761781289","url":"https:\/\/k12savings.com\/products\/alcohol-drugs-and-medication-in-pregnancy-isbn-9781898683889","provider":"K12savings","version":"1.0","type":"link"}